Unexplained Recurrent Spontaneous Abortion
Conditions
Interventions
Bushen Huoxue prescription combined with aspirin group:Bushen Huoxue prescription combined with aspirin for 3 months
Bushen Huoxue formula combined with aspirin placebo group:Bushen Huoxue prescription combined with aspirin placebo treatment for 3 months
Bushen Huoxue formula placebo combined with aspirin group:Bushen Huoxue prescription placebo combined with aspirin
Bushen Huoxue prescription placebo combined with aspirin placebo group:Bushen Huoxue prescription placebo combined with aspirin placebo was administered for 3 months
Sponsors
The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: (1) Women of childbearing age, aged 20-40 years; (2) Normal menstrual cycle (28~30 days); (3) Urine pregnancy test is negative, blood ß-HCG < 5IU/L, consent to use contraceptives during the medication; (4) The diagnostic criteria of URSA Western medicine and syndrome of kidney deficiency and blood stasis of slippery fetus were met; (5) Sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with a clear cause of RSA; (2) The male etiology is clearly abnormal; (3) complicated with other diseases (such as diabetes mellitus, neoplasms, digestive diseases, heart, liver, kidney, blood system diseases and neuropsychiatric diseases); (4) genital tract abnormalities and endocrine abnormalities; (5) Clear trauma, ovulation disorders, fallopian tube obstruction and other effects of re-conception; (6) Recent history of exposure to parasitic infections and harmful poisons. (7) pregnant and lactating women; (8) Those who have recently taken other medium (adult) drugs or taken hormone drugs within three months; (9) Those who cannot take the medicine on time for other reasons; (10) Patients participating in other clinical trials; (11) The researchers felt that other reasons were not appropriate for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Factors associated with angiogenesis;Factors associated with iron death; | — |
Secondary
| Measure | Time frame |
|---|---|
| Coagulation index;Uterine arterial blood perfusion;Safety index; | — |
Countries
China
Contacts
Public ContactXiaoling Feng
The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine
Outcome results
None listed